CTI LIFE SCIENCES FUND
CTI Life Sciences, a Canadian venture firm makes venture capital investments in high quality emerging life sciences companies at the pre-clinical and clinical development stage in Canada and in the U.S. CTI Life Sciences currently manage $345 million of assets.
CTI LIFE SCIENCES FUND
Industry:
Clinical Trials Life Science Venture Capital
Founded:
2006-01-01
Status:
Active
Contact:
514 787 1620
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Current Employees Featured
Jean-Francois Leprince Managing Partner @ CTI Life Sciences Fund
Managing Partner
Laurence Rulleau Partner @ CTI Life Sciences Fund
Partner
2014-12-01
Ken Pastor General Partner & Co-Founder @ CTI Life Sciences Fund
General Partner & Co-Founder
2006-06-01
Shermaine Tilley Managing Partner @ CTI Life Sciences Fund
Managing Partner
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-05-10 | Domain Therapeutics | CTI Life Sciences Fund investment in Series A - Domain Therapeutics | 39 M EUR |
| 2022-04-25 | Epitopea | CTI Life Sciences Fund investment in Seed Round - Epitopea | 10.3 M GBP |
| 2020-10-07 | Phenomic AI | CTI Life Sciences Fund investment in Seed Round - Phenomic AI | 6 M USD |
| 2020-08-01 | Find therapeutics | CTI Life Sciences Fund investment in Seed Round - Find therapeutics | N/A |
| 2020-06-08 | Phenomic AI | CTI Life Sciences Fund investment in Seed Round - Phenomic AI | 3 M EUR |
| 2020-03-06 | Vaxcyte | CTI Life Sciences Fund investment in Series D - Vaxcyte | 110 M USD |
| 2018-06-18 | Phenomic AI | CTI Life Sciences Fund investment in Seed Round - Phenomic AI | 2 M USD |
| 2017-10-05 | Visterra | CTI Life Sciences Fund investment in Series C - Visterra | 23.6 M USD |
| 2017-07-27 | PreciThera | CTI Life Sciences Fund investment in Series A - PreciThera | 36 M CAD |
| 2017-06-27 | PHEMI | CTI Life Sciences Fund investment in Series B - PHEMI | 10 M USD |
More informations about "CTI Life Sciences Fund"
Portfolio - CTI Life Sciences
A Fund I company, GLyPharma Therapeutic Inc. (GlyPharma) was a new company created in Montreal for the purpose of a strategic partnership between Ferring Pharmaceuticals (Ferring), a European pharmaceutical company, …See details»
CTI Life Sciences Fund - Crunchbase Investor Profile
Legal Name CTI Life Sciences Fund, L.P. Investor Type Venture Capital Investment Stage Early Stage Venture, Late Stage Venture, Post-Ipo, Venture Number of Exits . obfuscated. obfuscated. Phone Number 514 787 1620; CTI …See details»
CTI Life Sciences Fund investment portfolio | PitchBook
Apr 9, 2021 CTI Life Sciences Fund General Information Company Description. Founded in 2006 CTI Life Sciences Fund is a venture capital firm based in Montreal, Canada. The firm prefers to invest in the life sciences and …See details»
CTI Life Sciences - Mink Capital
CTI Life Sciences Fund strategy revolves around the "Inception-2-Inflection" concept. We will invest from birthing new companies to more advanced-clinical-stage organizations. Our …See details»
CTI Life Sciences Fund Successfully Raises $100 Million As A
May 10, 2021 CTI Life Sciences Fund announced today the first closing of its third venture capital fund (“CTI LSF III”), with $100M CDN of capital now available for investment. The new …See details»
CTI Life Sciences Fund - Synapse Life Science Consortium
Based in Montréal and Toronto, CTI Life Sciences Fund, a Canadian venture firm makes venture capital investments in high quality emerging life science companies at the pre-clinical and …See details»
CTI Life Sciences - Venbridge
CTI Life Sciences Fund makes venture capital investments in high quality emerging life science companies at the pre-clinical and clinical development stages. Our main guiding principle is to catalyze, transform and invest in the …See details»
CTI Life Sciences Fund - Funding, Financials, Valuation & Investors
CTI Life Sciences Fund has raised 3 funds, their latest being CTI Life Sciences Fund III. This fund was announced on May 10, 2021 and raised a total of . obfuscated. obfuscated. Announced …See details»
CTI Life Sciences Fund I: Performance - PitchBook
CTI Life Sciences Fund I Fund is a venture capital fund managed by CTI Life Sciences Fund. The fund is located in Montreal, Canada and invests in the Canada. The fund targets …See details»
Cti Life Sciences Fund is based in , Canada | Angels Partners
About The Fund. Founded in 2006 CTI Life Sciences Fund is a venture capital investment firm that is based in Montreal, Canada. The firm invests in the life sciences and healthcare …See details»
CTI Life Sciences Fund - Investor in Montreal, Quebec - Ask For …
CTI Life Sciences Fund makes venture capital investments in high-quality emerging life science companies at the pre-clinical and clinical development stages. Our main guiding principle is to …See details»
CTI Life Sciences | BDC.ca
CTI Life Sciences, Inc. is a Montreal-based, early stage VC firm that invests primarily in pre-clinical and early clinical-stage therapeutics companies, with a secondary focus on mid-and …See details»
CTI Life Sciences Fund - Investments, Portfolio & Company Exits
CTI Life Sciences Fund 's most notable exits include Vaxcyte, Amolyt Pharma, and Zymeworks. Which industries has this organization had the most exits in? Show . Vaxcyte Vaxcyte focuses …See details»
CTI Life Sciences Fund: Contact Details and Business Profile
CTI Life Sciences Fund strategy revolves around the "Inception-2-Inflection" concept. We will invest from birthing new companies to more advanced-clinical-stage organizations. The Fund …See details»
CTI Life Sciences Fund - CB Insights
Jan 15, 2015 CTI is a Montreal-based limited partnership making venture capital investments in emerging life sciences companies at the start-up and clinical development stage in North …See details»
CTI Life Sciences Fund Raises $100 Million As A First ... - BIOQuébec
MONTREAL, May 10, 2021 /CNW Telbec/ - CTI Life Sciences Fund announced today the first closing of its third venture capital fund ("CTI LSF III"), with $100M CDN of capital now …See details»
CTI LIFE SCIENCES FUND L.P. - Domain Therapeutics Group
CTI Life Sciences Fund L.P. is a Montreal-based company founded in 2006. The firm makes venture capital investments mostly in innovative high-quality biotech companies at the pre …See details»
CTI Life Sciences Fund - Private Equity International
CTI Life Sciences Fund News, insights, analysis and data Founded in 2006, CTI Life Sciences Fund is a Montreal-based investment firm that focuses on early-stage investments in …See details»
CTI Life Sciences Fund Successfully Raises $100 Million As A First ...
MONTREAL, May 10, 2021 /CNW Telbec/ - CTI Life Sciences Fund announced today the first closing of its third venture capital fund ("CTI LSF III"), with $100M CDN of capital now …See details»
Canada launches $200M genomics data initiative to drive precision ...
Mar 5, 2025 The Canadian Precision Health Initiative is led by Genome Canada and supported by $81 million in federal investment and an estimated total investment of $200 million, …See details»